Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Dr Brian McClelland presented a proposal for a prospective study of Post Transfusion Hepatitis to the MRC Working Party.

Published on: 22 July, 2024

The MRC Working Party took no decision regarding Dr Brian McClelland's proposal for a prospective study of Post Transfusion Hepatitis.

Published on: 22 July, 2024

The MRC Blood Transfusion Research Committee agreed there was no need for surrogate screening for NANBH.

Published on: 22 July, 2024

Journal of the American Medical Association published NIH study.

Published on: 22 July, 2024

The Lancet published the outcome of a study in Australia with similar findings as the TTV study.

Published on: 22 July, 2024

No decision was taken by Working Party on further study proposal from Dr Brian McClelland.

Published on: 22 July, 2024

Working Party on Transfusion-Associated Hepatitis focused on AIDS – no further discussion of prospective study of NANBH markers.

Published on: 22 July, 2024

Report produced on NANBH in the West of Scotland by Drs Dow and Follett.

Published on: 22 July, 2024

FDA recommended the introduction of both ALT and anti-HBc testing.

Published on: 22 July, 2024

Working Party on Transfusion-Associated Hepatitis reconvened for the first time since 1983 and proposed to discuss a protocol for a multi-centre study.

Published on: 22 July, 2024

SNBTS minutes recorded decision to introduce surrogate testing next year.

Published on: 22 July, 2024

Letter in The Lancet from SNBTS suggested that surrogate testing was "inescapable".

Published on: 22 July, 2024

DHSS granted funding for multi-centre study.

Published on: 22 July, 2024

The Chiron Corporation identified and cloned Hepatitis C virus.

Published on: 22 July, 2024

Dr Craske wrote to Dr Barbara that he did not favour the use of anti-HBc screening.

Published on: 22 July, 2024

At the meeting of the regional transfusion directors, it was noted that the most risky populations might had been identifiable by anti-HBc markers, however no further discussion took place.

Published on: 22 July, 2024

At a meeting of the UK Working Party on Transfusion-Associated Hepatitis, Dr Barbara observed that the anti-HBc test had the value of association with Hepatitis B and NANBH as well as AIDS.

Published on: 22 July, 2024

The CBLA Working Group on AIDS discussed surrogate screening and asked Dr Brian McClelland to submit outline proposals for prospective study.

Published on: 22 July, 2024

The CBLA Working Group on AIDS agreed that a protocol for a study should be drawn up.

Published on: 22 July, 2024

Dr Wallington presented the protocol for a study on surrogate screening at the CBLA Central Committee for Research and Development in Blood Transfusion.

Published on: 22 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2073
  • Page 2074
  • Page 2075
  • Page 2076
  • Current page 2077
  • Page 2078
  • Page 2079
  • Page 2080
  • Page 2081
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.